Published in J Trauma on August 01, 1987
Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg (1996) 2.24
Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care (2002) 1.54
Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun (1997) 1.44
Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg (1990) 1.22
Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol (1992) 0.91
Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia. Clin Diagn Lab Immunol (2004) 0.90
Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis. J Orthop Res (2011) 0.89
Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. Ann Surg (1989) 0.89
Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis. Infect Immun (1995) 0.89
Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock. Ann Surg (1991) 0.88
Immune response of severely injured patients--influence of surgical intervention and therapeutic impact. Langenbecks Arch Surg (2007) 0.87
Current views on the mechanisms of immune responses to trauma and infection. Cent Eur J Immunol (2015) 0.83
Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg (1991) 0.83
Total IgE in plasma is elevated after traumatic injury and is associated with sepsis syndrome. Ann Surg (1992) 0.82
PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity. Brain Behav Immun (2012) 0.80
Mediators of multiple organ failure. Intensive Care Med (1990) 0.78
Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure. J Adv Nutr Hum Metab (2015) 0.78
Expression and secretion of IL-2 receptor in trauma patients. Ann Surg (1990) 0.77
Defective T-cell surface antigen expression after mitogen stimulation. An index of lymphocyte dysfunction after controlled murine injury. Ann Surg (1989) 0.76
Lipopolysaccharide-reactive immunoglobulin E is associated with lower mortality and organ failure in traumatically injured patients. Clin Diagn Lab Immunol (1994) 0.75
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J (1991) 11.86
In vitro transcription of adenovirus. J Virol (1981) 7.06
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ (1980) 5.66
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Messenger RNA for the Ad2 DNA binding protein: DNA sequences encoding the first leader and heterogenity at the mRNA 5' end. Cell (1979) 5.28
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol (1981) 5.01
Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet (1994) 4.06
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J (1987) 3.77
Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery (1983) 3.65
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol (1989) 3.55
Epidemiology of trauma deaths. Am J Surg (1980) 2.58
Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock (1998) 2.51
Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol (1994) 2.49
Transient replication of human papillomavirus DNAs. J Virol (1992) 2.43
The control of rheumatic fever and rheumatic heart disease: an outline of WHO activities. WHO Chron (1973) 2.37
Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol Cell Biol (1998) 2.23
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07
A comparison of the association of helicopter and ground ambulance transport with the outcome of injury in trauma patients transported from the scene. J Trauma (1997) 1.97
Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest (1979) 1.94
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Antigen recognition and the immune response. Humoral and cellular immune responses to small mono- and bifunctional antigen molecules. J Exp Med (1972) 1.86
Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing. Mol Ther (2001) 1.84
Multiple organ failure in polytrauma patients. J Trauma (1983) 1.81
T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med (1999) 1.76
The genetics of bovine papillomavirus type 1. Annu Rev Genet (1988) 1.75
Acute appendicitis following blunt abdominal trauma. Incidence or coincidence? Ann Surg (1991) 1.72
An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J Virol (1991) 1.68
Alteration of monocyte function following major injury. Arch Surg (1988) 1.64
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Antigen recognition and the immune response: the capacity of L-tyrosine-azobenzenearsonate to serve as a carrier for a macromolecular hapten. J Immunol (1971) 1.57
Monoclonal anti-CD4 in arthritis. Lancet (1987) 1.55
Predicting fatal sepsis in burn patients. J Trauma (1979) 1.54
The self-measurement of blood pressure: an experiment with office workers at their place of work. Bull World Health Organ (1972) 1.53
Biogenesis, structures, and sites of encoding of the 5' termini of adenovirus-2 mRNAs. Cold Spring Harb Symp Quant Biol (1980) 1.52
The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock (1996) 1.46
Towards a better definition of human leucocyte surface molecules. Immunol Today (1989) 1.42
Surgical intervention following fragmentation of gallstones by extracorporeal shock waves. World J Surg (1989) 1.42
Epidemiology of trauma: the civilian perspective. Ann Emerg Med (1986) 1.39
Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J Virol (1996) 1.39
Subtypes of T-cell chronic lymphatic leukemia. Cancer (1983) 1.39
A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc Natl Acad Sci U S A (1998) 1.37
Cardiac contusion. The effect on operative management of the patient with trauma injuries. Arch Surg (1989) 1.37
Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg (1986) 1.34
Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest (1996) 1.29
The role of emergency room thoracotomy in trauma. J Trauma (1980) 1.27
Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci U S A (1989) 1.25
The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ (1981) 1.25
Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5'-noncoding region. J Med Virol (1995) 1.22
Results of gastric resection for carcinoma of the stomach: the European experience. World J Surg (1988) 1.21
Cystoid macular edema in pseudophakia. Surv Ophthalmol (1984) 1.21
Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol (1993) 1.21
Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Neurology (1997) 1.20
Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-beta 1. Mol Endocrinol (1987) 1.19
Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol (1996) 1.18
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity (1993) 1.18
Antigen-induced proliferation assay for mouse T lymphocytes. Response to a monovalent antigen. Eur J Immunol (1978) 1.16
Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J Virol (1995) 1.16
Functional analysis of monocyte subsets in surgical sepsis. J Trauma (1998) 1.15
Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis (2005) 1.11
Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun (1989) 1.11
Uptake, release and metabolism of docosahexaenoic acid (DHA, c22:6 omega 3) in human platelets and neutrophils. Biochem Biophys Res Commun (1984) 1.11
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet (1991) 1.11
Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid. Proc Natl Acad Sci U S A (1985) 1.10
Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma (1994) 1.09
Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers. J Virol (1997) 1.09
Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo. J Virol (2000) 1.08
Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl (1989) 1.07
A subset of human cells isolated and characterized by monoclonal antibodies. Eur J Immunol (1981) 1.06
Nonoperative management of adult blunt splenic trauma. Criteria for successful outcome. Ann Surg (1989) 1.04
An analysis of the association of trauma centers with per capita hospitalizations and death rates from injury. Ann Surg (1993) 1.04
Accuracy of administrative data in trauma. Surgery (1999) 1.04
Poly(A) sites of adenovirus serotype 2 transcription units. J Mol Biol (1982) 1.04
The complete amino acid sequence of the light chain variable region of two monoclonal anti-p-azobenzene-arsonate antibodies bearing the cross-reactive idiotype. Mol Immunol (1983) 1.01
Antigen recognition and the immune response. "Self-help" with symmetrical bifunctional antigen molecules. J Exp Med (1972) 1.00
CD antigens 1989. Blood (1989) 0.99
Intraocular lenses: complications and visual results. Trans Am Ophthalmol Soc (1983) 0.98
Identity of mononuclear cells which compromise the resistance of trauma patients. J Surg Res (1979) 0.98
Comparison of the ability of adult and pediatric trauma scores to predict pediatric outcome following major trauma. J Trauma (1991) 0.98
WHO-WHL Hypertension Management Audit Project. J Hum Hypertens (1993) 0.98
Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res (1990) 0.98
Characterization of accessory cells required for helper T cell induction in vitro: evidence for a phagocytic, Fc-receptor, and Ia-bearing cell type. J Immunol (1980) 0.97
A statewide, population-based time-series analysis of the increasing frequency of nonoperative management of abdominal solid organ injury. Ann Surg (1995) 0.96
Management outcomes in splenic injury: a statewide trauma center review. Ann Surg (1997) 0.96
Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J Allergy Clin Immunol (1997) 0.95
Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J Trauma (1990) 0.95
Promoters of bovine papillomavirus type 1: in vitro activity and utilization. J Virol (1988) 0.95
Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int J Cancer (1985) 0.95
The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region. Mol Cell Biol (1995) 0.95
Vascular injuries in a rural state: a review of 978 patients from a state trauma registry. J Trauma (1992) 0.95
Structural characterization of antiidiotypic antibodies. Evidence that Ab2s are derived from the germline differently than Ab1s. J Exp Med (1989) 0.94